Qube Research & Technologies LTD Prothena Corp Public LTD CO Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Qube Research & Technologies LTD holds 13,320 shares of PRTA stock, worth $202,730. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,320
Holding current value
$202,730
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$16.73 - $24.79 $222,843 - $330,202
13,320 New
13,320 $222,000
Q1 2024

May 14, 2024
SELL
$24.75 - $40.66 $203,841 - $334,875
-8,236 Reduced 4.04%
195,446 $4.84 Million
Q4 2023

Feb 13, 2024
BUY
$32.31 - $52.32 $3.85 Million - $6.23 Million
119,029 Added 140.61%
203,682 $7.4 Million
Q3 2023

Nov 13, 2023
BUY
$47.3 - $70.6 $2.05 Million - $3.05 Million
43,256 Added 104.49%
84,653 $4.08 Million
Q2 2023

Aug 14, 2023
BUY
$48.26 - $78.59 $1.6 Million - $2.61 Million
33,159 Added 402.51%
41,397 $2.83 Million
Q1 2023

May 15, 2023
BUY
$46.97 - $58.27 $48,754 - $60,484
1,038 Added 14.42%
8,238 $399,000
Q4 2022

Feb 14, 2023
BUY
$52.05 - $65.0 $374,760 - $468,000
7,200 New
7,200 $433,000
Q2 2022

Aug 15, 2022
BUY
$22.73 - $39.98 $179,771 - $316,201
7,909 Added 132.5%
13,878 $377,000
Q1 2022

May 09, 2022
SELL
$30.27 - $49.22 $419,663 - $682,386
-13,864 Reduced 69.9%
5,969 $218,000
Q4 2021

Feb 01, 2022
BUY
$42.11 - $73.26 $835,167 - $1.45 Million
19,833 New
19,833 $980,000
Q4 2020

Feb 16, 2021
SELL
$10.12 - $13.94 $144,169 - $198,589
-14,246 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$9.93 - $13.47 $51,685 - $70,111
-5,205 Reduced 26.76%
14,246 $142,000
Q2 2020

Aug 14, 2020
BUY
$9.56 - $12.51 $185,951 - $243,332
19,451 New
19,451 $203,000

Others Institutions Holding PRTA

# of Institutions
184
Shares Held
42.7M
Call Options Held
162K
Put Options Held
102K
View Full List

About PROTHENA CORP PUBLIC LTD CO

PRTA Quotes by TradingView
  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $714M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email